Literature DB >> 15182953

Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors.

Wei-Ping Zhang1, Hua Hu, Lei Zhang, Wei Ding, Hong-Tian Yao, Ke-Da Chen, Wen-Wen Sheng, Zhong Chen, Er-Qing Wei.   

Abstract

Cysteinyl leukotrienes (CysLTs) are potent proinflammatory mediators. CysLT receptor 1 (CysLT(1)) is one of the two CysLT receptors that has been cloned. Although the expression of CysLT(1) in the brain has been demonstrated by Northern blot and RT-PCR analyses, the location of CysLT(1) in the brain remains unknown. The objective of this study was to examine the distribution of CysLT(1) by immunohistochemical analysis in human brains with traumatic injury or tumors. CysLT(1) was expressed intensely in the microvascular endothelial cells in both normal and abnormal conditions. At 8 days after traumatic injury, microvascular regeneration was found and all of the endothelial cells highly expressed CysLT(1). In gray and white matters of the normal regions of the brain, CysLT(1) was expressed weekly or not at all. However, the CysLT(1) expression increased in the neuron- and glial-appearing cells in gray and white matters after traumatic brain injury. CysLT(1) was also detected in astrocytoma, ganglioglioma and metastatic adenocarcinoma, and the expression in the neuron- and glial-appearing cells around brain tumors increased robustly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15182953     DOI: 10.1016/j.neulet.2004.03.088

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

1.  Blocking leukotriene synthesis attenuates the pathophysiology of traumatic brain injury and associated cognitive deficits.

Authors:  Chelsea E Corser-Jensen; Dayton J Goodell; Ronald K Freund; Predrag Serbedzija; Robert C Murphy; Santiago E Farias; Mark L Dell'Acqua; Lauren C Frey; Natalie Serkova; Kim A Heidenreich
Journal:  Exp Neurol       Date:  2014-03-25       Impact factor: 5.330

2.  Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury.

Authors:  Santiago Farias; Lauren C Frey; Robert C Murphy; Kim A Heidenreich
Journal:  J Neurotrauma       Date:  2009-11       Impact factor: 5.269

3.  Hippocampal CysLT1R knockdown or blockade represses LPS-induced depressive behaviors and neuroinflammatory response in mice.

Authors:  Jing-Ran Lin; Shun-Chang Fang; Su-Su Tang; Mei Hu; Yan Long; Arijit Ghosh; Hong-Bin Sun; Ling-Yi Kong; Hao Hong
Journal:  Acta Pharmacol Sin       Date:  2017-01-23       Impact factor: 6.150

Review 4.  Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer.

Authors:  Sayeh Savari; Katyayni Vinnakota; Yuan Zhang; Anita Sjölander
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

5.  Effects of MK-886, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice.

Authors:  Tolga Uz; Nikola Dimitrijevic; Marta Imbesi; Hari Manev; Radmila Manev
Journal:  Neurosci Lett       Date:  2008-03-21       Impact factor: 3.046

6.  Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice.

Authors:  Xu-Ben Yu; Rong-Rong Dong; Hui Wang; Jing-Ran Lin; Yun-Qi An; Yong Du; Su-Su Tang; Mei Hu; Yan Long; Hong-Bin Sun; Ling-Yi Kong; Hao Hong
Journal:  Psychopharmacology (Berl)       Date:  2015-11-07       Impact factor: 4.530

Review 7.  Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Yaaser Q Almulaiky; Natália Cruz-Martins; Gaber El-Saber Batiha
Journal:  Eur J Pharmacol       Date:  2021-05-15       Impact factor: 4.432

Review 8.  Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system.

Authors:  Jonathan Bertin; Corinne Barat; Sylvie Méthot; Michel J Tremblay
Journal:  Retrovirology       Date:  2012-01-11       Impact factor: 4.602

9.  Leukotrienes inhibit early stages of HIV-1 infection in monocyte-derived microglia-like cells.

Authors:  Jonathan Bertin; Corinne Barat; Dave Bélanger; Michel J Tremblay
Journal:  J Neuroinflammation       Date:  2012-03-16       Impact factor: 8.322

10.  CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer.

Authors:  Sayeh Savari; Minghui Liu; Yuan Zhang; Wondossen Sime; Anita Sjölander
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.